Is semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting in the phase II hypo-FLAME 2.0 trial associated with acceptable acute toxicity? L. De Cock, C. Draulans, F.J. Pos,S. Isebaert,R. De Roover,U.A. Van Der Heide, R.J. Smeenk, M. Kunze-Busch, L.G.W. Kerkmeijer, K. HaustermansEuropean Urology Open Science（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
